PRSO.NASDAQPeraso INC

10-Q: Peraso Q3 Sees mmWave Growth Amidst Strategic Review, Going Concern Warning

Sentiment:

Quarterly Report


Peraso Inc. reported improved net loss in Q3 2025 driven by mmWave growth and cost reductions, but faces a going concern warning and is evaluating a Mobix Labs acquisition proposal.

Capital raiseThe company has historically financed operations through multiple offerings of common stock and warrants, and convertible notes and loans.Successfully completed a warrant inducement offering in September 2025, generating approximately $0.9 million in net proceeds.Sold 2,003,207 shares of common stock for approximately $2.27 million in net proceeds through an at-the-market (ATM) offering program during the nine months ended September 30, 2025.Subsequent to September 30, 2025, sold an additional 929,737 shares of common stock for approximately $1.37 million in net proceeds via the ATM program.Increased the maximum aggregate offering amount of common stock issuable pursuant to the Sales Agreement (ATM program) to $1,750,000 on October 10, 2025.Management explicitly states the company is "currently seeking additional financing in order to meet its cash requirements for the foreseeable future" and will need to raise substantial additional capital to continue operations beyond Q1 2026.Warns that if additional capital is raised through equity, stockholders would suffer dilution, and debt financing may impose restrictive terms.
Worse than expectedThe company continues to incur significant net losses ($3.51 million for nine months ended September 30, 2025) and has an accumulated deficit of $180.6 million.Net cash used in operating activities increased to $4.56 million for the nine months ended September 30, 2025, indicating a higher cash burn rate.Cash and cash equivalents decreased significantly from $3.34 million at December 31, 2024, to $1.87 million at September 30, 2025.Management explicitly states that existing cash and expected receipts will only meet capital needs into the first quarter of 2026, necessitating further capital raises.Both management and the independent registered public accounting firm expressed "substantial doubt" about the company's ability to continue as a going concern within one year.Total net revenue decreased by 14% for the nine months ended September 30, 2025, primarily due to the end-of-life of the memory IC product line, which previously constituted a significant portion of revenue.

Summary

  • Net loss significantly improved for both the three months ($1.21 million vs. $2.71 million) and nine months ($3.51 million vs. $9.17 million) ended September 30, 2025, compared to the same periods in 2024.
  • Total net revenue decreased by 16% to $3.23 million for the three months and 14% to $9.32 million for the nine months ended September 30, 2025, primarily due to the end-of-life of memory IC products.
  • mmWave ICs and modules revenue saw substantial growth, with mmWave ICs increasing from $67,000 to $2.28 million (Q3) and $272,000 to $4.57 million (9 months), and mmWave modules from $60,000 to $658,000 (Q3) and $817,000 to $2.10 million (9 months).
  • Operating expenses decreased significantly, with R&D down 29% to $1.53 million (Q3) and 37% to $4.77 million (9 months), and SG&A down 37% to $1.48 million (Q3) and 32% to $4.50 million (9 months), due to cost reduction initiatives.
  • The company's independent registered public accounting firm expressed substantial doubt about its ability to continue as a going concern, a sentiment echoed by management.
  • Peraso is engaged in a strategic review process, including evaluating an unsolicited, non-binding acquisition proposal from Mobix Labs, Inc., which most recently offered $1.30 per share in cash.
  • Cash and cash equivalents stood at $1.87 million as of September 30, 2025, down from $3.34 million at December 31, 2024.
  • Net cash used in operating activities increased to $4.56 million for the nine months ended September 30, 2025, compared to $3.89 million in the prior year.

Sentiment

Score: 3

Explanation: While the company showed improved net loss and strong mmWave growth, the persistent net losses, increased cash burn, dwindling cash reserves, and explicit 'going concern' warning from both management and auditors indicate a highly precarious financial position. The ongoing strategic review and need for immediate capital raise underscore significant operational and financial challenges, despite efforts to cut costs and grow the mmWave segment.

Positives

  • Significant improvement in net loss for both the three-month (down 55% to $1.21 million) and nine-month (down 62% to $3.51 million) periods ended September 30, 2025, year-over-year.
  • Substantial growth in mmWave ICs revenue, increasing from $67,000 to $2.28 million for the three months and $272,000 to $4.57 million for the nine months ended September 30, 2025.
  • Strong growth in mmWave modules revenue, rising from $60,000 to $658,000 for the three months and $817,000 to $2.10 million for the nine months ended September 30, 2025.
  • Gross profit remained relatively flat despite a decrease in total net revenue, indicating improved product mix and contribution from royalty and other revenues, as well as sales of previously written-down mmWave inventory.
  • Operating expenses significantly reduced due to cost reduction initiatives, including employee lay-offs and termination of consulting contracts, with R&D down 29% and SG&A down 37% for the three months ended September 30, 2025.
  • Regained compliance with Nasdaq's minimum bid price requirement on September 19, 2025.
  • Successfully raised $0.9 million in net proceeds from a warrant inducement offering in September 2025 and $2.27 million from at-the-market stock sales during the nine months ended September 30, 2025.

Negatives

  • Total net revenue decreased by 16% to $3.23 million for the three months and 14% to $9.32 million for the nine months ended September 30, 2025, primarily due to the end-of-life of memory IC products.
  • Memory IC product revenue significantly declined from $3.68 million to $72,000 for the three months and $9.49 million to $2.34 million for the nine months ended September 30, 2025, due to the discontinuation of the foundry process by TSMC.
  • The company incurred net losses of $3.51 million for the nine months ended September 30, 2025, and has an accumulated deficit of $180.6 million.
  • Net cash used in operating activities increased to $4.56 million for the nine months ended September 30, 2025, compared to $3.89 million in the prior year, indicating higher cash burn.
  • Cash and cash equivalents decreased to $1.87 million as of September 30, 2025, from $3.34 million at December 31, 2024.
  • Management and the independent registered public accounting firm expressed substantial doubt about the company's ability to continue as a going concern within one year.
  • The company expects to continue incurring operating losses and cash burn for the foreseeable future, with existing cash only sufficient into the first quarter of 2026.
  • The strategic review process, including the Mobix Labs proposal, creates uncertainty and may divert management's attention and resources.

Risks

  • Inability to continue as a going concern due to recurring net losses and negative cash flows, with existing cash and expected receipts only sufficient into the first quarter of 2026.
  • Uncertainty regarding the availability or acceptable terms of additional capital (debt or equity financing), which could lead to dilution for existing stockholders or restrictive debt covenants.
  • The strategic review process, including the Mobix Labs proposal, may not lead to a favorable outcome, could create business disruption, and increase stock price volatility.
  • Potential delisting from Nasdaq if the company fails to satisfy continued listing requirements, such as the minimum bid price or minimum equity requirements, which could adversely affect liquidity and investor interest.
  • The discontinuation of memory IC product production by TSMC will negatively impact future revenues, results of operations, and cash flows, as memory ICs represented 25% of revenues for the nine months ended September 30, 2025, and 87% in the prior year.
  • The reduction in force implemented in November 2023 may not achieve intended outcomes, could lead to unintended consequences like loss of institutional knowledge, decreased morale, and difficulty in pursuing new opportunities.
  • International trade policies, including protectionist measures like tariffs and sanctions, could adversely affect business, increase costs of raw materials, reduce margins, and harm competitive position.
  • Exposure to risks from competition, rapidly changing customer requirements, limited operating history, tariffs, pandemics, wars, acts of terrorism, and volatility of public markets.
  • Significant non-cancelable purchase obligations for inventory (wafers and substrates) totaling approximately $2.7 million as of September 30, 2025.

Future Outlook

The company expects to continue incurring operating losses and cash burn for the foreseeable future as it secures additional customers and invests in mmWave product commercialization. Revenues need to increase substantially to generate sustainable operating profit and sufficient cash flows without additional capital raises. Existing cash and expected receipts are projected to meet capital needs only into the first quarter of 2026. Total R&D expenses are expected to decrease for the remainder of 2025 compared to 2024 due to cost reduction initiatives, while total SG&A expense is expected to remain flat or slightly decrease.

Management Comments

  • Our strategy and primary business objective is to be a profitable, IP-rich fabless semiconductor company offering integrated circuits, or ICs, antenna modules and related non-recurring engineering services.
  • We have pioneered a high-volume mmWave IC production test methodology using standard, low-cost production test equipment. It has taken us several years to refine performance of this production test methodology, and we believe this places us in a leadership position in addressing the operational challenges of delivering mmWave products into high-volume markets.
  • With our module, we can guarantee the performance of the amplifier/antenna interface and simplify customers radio frequency, or RF, engineering, facilitating more opportunities for customer prospects that have not provided RF-type systems, as well as shortening the time to market for new products.
  • Our board of directors is evaluating the Company’s options to enhance stockholder value. Our board of directors and management team are committed to acting in the best interests of all stockholders.
  • We do not intend to make further comments regarding potential transactions or provide any public updates regarding proposed or potential transactions, unless required by applicable law or a regulatory body.
  • We believe that our existing cash and cash equivalents as of September 30, 2025 and expected receipts associated with forecasted product sales will enable us to meet our capital needs into the first quarter of 2026.
  • If we are unsuccessful in these efforts [seeking additional financing], we will need to implement additional cost reduction strategies, which could further affect our nearand long-term business plan. These cost reduction strategies may include, but are not limited to, reducing headcount and curtailing business activities.

Industry Context

Peraso Inc. operates in the highly competitive fabless semiconductor industry, specializing in mmWave wireless technology, a growing segment for 802.11ad/ay and 5G applications. The company's focus on high-volume mmWave IC production test methodology and integrated antenna modules positions it to address operational challenges and simplify RF engineering for customers, potentially shortening time-to-market for new products. The discontinuation of its memory IC product line, due to TSMC discontinuing the foundry process, marks a strategic shift towards its core mmWave business. The ongoing strategic review and unsolicited acquisition proposal from Mobix Labs highlight the consolidation trends and competitive pressures within the semiconductor sector, particularly for smaller, specialized players facing liquidity challenges.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Accounting Standard AdoptionAdopted ASC No. 280, Segment Reporting, as amended by ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, effective December 31, 2024.December 31, 2024Management evaluates financial performance and makes operating decisions on a consolidated basis, thus the company operates and manages its business as one reportable and operating segment.
Accounting Standard EvaluationEvaluating the impact of FASB ASU No. 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosures about specific types of expenses.January 1, 2027 (annual periods), January 1, 2028 (interim periods)The company is evaluating the impact this ASU will have on the presentation of its consolidated financial statements.

Legal Proceedings

  • The company is not a party to any legal proceeding believed to have a material adverse effect on its financial position or results of operations.
  • May be subject to legal proceedings and claims in the ordinary course of business, which could result in significant financial resources expenditure and diversion of management efforts.

Related Party Transactions

  • Compensation expense of approximately $31,200 for the three months ended September 30, 2025, and $88,900 for the nine months ended September 30, 2025, was recorded for a family member of an executive officer employed by the company.

Stakeholder Impact

  • Shareholders: Face significant dilution risk from potential future equity raises; uncertainty regarding the outcome of the strategic review process and Mobix Labs' acquisition proposal; potential for increased stock price volatility; risk of losing most or all investment if the company cannot continue as a going concern.
  • Employees: Potential for further headcount reductions if additional financing is not secured; risk of decreased morale and loss of institutional knowledge due to past reductions in force.
  • Customers: Potential for disruption if the company's financial instability impacts product development or supply chain, though mmWave product growth is positive.
  • Creditors: Increased risk due to the "going concern" warning and the company's need for additional capital.
  • Suppliers: Risk related to outstanding non-cancelable purchase orders ($2.7 million) if the company faces severe liquidity issues.

Next Steps

  • Continue the strategic review process to evaluate options for enhancing stockholder value, including the Mobix Labs acquisition proposal.
  • Seek additional financing through debt or equity arrangements to meet cash requirements beyond Q1 2026.
  • Implement further cost reduction strategies, such as reducing headcount and curtailing business activities, if additional financing is unsuccessful.
  • Evaluate the impact of the new FASB ASU No. 2024-03 on the presentation of consolidated financial statements.
  • Continue to manage SG&A costs to keep them flat or slightly decreasing for the remainder of 2025.
  • Pay remaining software license contractual liabilities of approximately $0.2 million by December 31, 2025.

Key Dates

DateDescription
1991Company incorporated in California (as MoSys, Inc.).
2000Company reincorporated in Delaware.
2009Peraso Technologies Inc. 2009 Share Option Plan adopted.
2010Company adopted the 2010 Equity Incentive Plan.
20142010 Equity Incentive Plan amended.
20172010 Equity Incentive Plan amended.
20182010 Equity Incentive Plan amended.
August 2019Amended 2010 Plan terminated; 2019 Stock Incentive Plan approved by stockholders.
September 14, 2021Company entered into Arrangement Agreement with Peraso Technologies Inc. to acquire all outstanding common shares.
November 2021Stockholders approved amendment increasing shares reserved for issuance under the 2019 Plan by 77,674 shares.
December 17, 2021Arrangement with Peraso Tech completed; Company changed name to Peraso Inc. and began trading on Nasdaq under PRSO.
March 1, 2022Company entered into a 36-month finance lease agreement for equipment.
May 2022Company entered into a lease for the Markham facility with a 60-month term.
June 21, 2022Markham facility lease commenced.
November 2022Registered direct offering completed, issuing Purchase Warrants.
November 1, 2022Company entered into a 36-month finance lease agreement for equipment.
2023Company received first installment of Markham lease incentive; commenced end-of-life (EOL) of memory products.
June 2023Registered direct offering completed, issuing Purchase Warrants.
November 2023Company implemented employee lay-offs and terminated consulting positions (Reductions).
December 15, 2023Company filed certificate of amendment for a 1-for-40 reverse stock split of common stock.
December 2024Stockholders approved amendment increasing shares reserved for issuance under the 2019 Plan by 1,500,000 shares; Toronto office lease renewed for one-year term.
December 31, 2024Company adopted ASU No. 2023-07, Segment Reporting.
January 1, 2025Toronto office lease commenced.
January 2, 2024Canco filed certificate of amendment for a 1-for-40 reverse stock split of exchangeable shares.
January 3, 2024Reverse stock split effective for trading purposes.
February 6, 2024Company entered into underwriting agreement for a public offering of common stock and warrants.
February 7, 2024Ladenburg partially exercised option for additional securities in the public offering.
February 8, 2024Public offering closed; Series A warrants issued (expire Feb 8, 2029); Series B warrants issued (expired Nov 8, 2024); pre-funded warrants issued (all exercised by Dec 31, 2024).
August 6, 2024Company extended expiration date of Series B warrants to October 7, 2024.
August 30, 2024Company entered into At The Market Offering Agreement (Sales Agreement) with Ladenburg.
October 3, 2024Company extended expiration date of Series B warrants to November 8, 2024.
November 5, 2024Company entered into inducement offer letter agreements with holders of Series B warrants for a reduced exercise price and issuance of Series C and Series D warrants.
November 6, 2024Warrant inducement offering closed, resulting in issuance of common stock, Series C warrants (expire Dec 5, 2025), and Series D warrants (expire Nov 6, 2029).
January 2025Company issued 40,000 unregistered shares of common stock to a service provider.
January 14, 2025Corporate headquarters facility lease in San Jose, California expired.
March 1, 2025Finance lease for equipment expired, and the Company took ownership.
March 2025Company fulfilled all then-outstanding EOL orders for memory IC products.
May 2, 2025Company extended expiration date of Series C Warrants to August 4, 2025.
June 27, 2025Company confirmed receipt of unsolicited, non-binding acquisition proposal from Mobix Labs, Inc.
July 2025Company received a refund of approximately $56,300 from a licensor for a terminated software license agreement; remaining severance liabilities fully paid.
July 11, 2025Company announced initiation of strategic review process.
August 4, 2025Company extended expiration date of Series C Warrants to December 5, 2025.
August 15, 2025Final invoice for the November 1, 2022 finance lease agreement for equipment.
August 19, 2025Company provided public update on strategic review process.
September 4, 2025Mobix Labs sent a letter with a revised acquisition proposal (cash and stock, undetermined amount).
September 5, 2025Mobix Labs sent a follow-up letter regarding confidentiality; Company received Nasdaq letter regarding minimum bid price non-compliance.
September 8, 2025Company provided public update on strategic review process regarding Mobix Labs letters.
September 10, 2025Limited exploratory call with Mobix Labs.
September 11, 2025Mobix Labs issued public statement describing enhanced proposal (30% cash, 70% stock); Company entered into inducement offer letter agreement for Series C to Series E warrant conversion.
September 12, 2025Company issued press release clarifying Mobix Labs statements; warrant inducement offering closed, resulting in $0.9 million net proceeds and issuance of Series E warrants (exercisable on 6-month anniversary, expire Sept 12, 2031).
September 13, 2025Mobix Labs filed Form 425 and announced intent to commence hostile exchange offer.
September 19, 2025Company received Nasdaq notification of regaining compliance with minimum bid price requirement.
September 29, 2025Mobix Labs delivered a definitive proposal to acquire all outstanding shares for $1.30 per share (cash and stock mix).
September 30, 2025End of quarterly period covered by the report; remaining contractual liabilities of $0.2 million for software licenses expected to be paid by December 31, 2025.
October 3, 2025Mobix Labs delivered an updated all-cash proposal of $1.30 per share.
October 6, 2025Company sent letter to Mobix Labs requesting clarification on proposal; Mobix Labs publicly announced updated all-cash proposal.
October 10, 2025Company increased maximum aggregate offering amount of common stock under Sales Agreement to $1,750,000.
October 15, 2025Related right-of-use asset and liability for the November 1, 2022 finance lease will be fully amortized.
October 30, 2025Company entered into a mutual confidentiality agreement with Mobix Labs, including 12-month standstill.
November 3, 2025Mobix Labs publicly announced entry into mutual confidentiality agreement.
November 7, 2025Number of outstanding exchangeable shares was 57,085; number of outstanding common stock shares was 8,924,662.
November 12, 2025Filing date of the Form 10-Q.
December 5, 2025Series C warrants expire.
May 28, 2028Warrants issued in November 2022 expire.
June 2, 2028Common Stock Warrants and Warrants issued in June 2023 expire.
February 8, 2029Series A warrants expire.
November 6, 2029Series D warrants expire.
September 12, 2030Placement Agent Warrants from Sept 2025 inducement offering expire.
September 12, 2031Series E warrants expire.
January 1, 2027Effective date for FASB ASU No. 2024-03 for annual periods.
January 1, 2028Effective date for FASB ASU No. 2024-03 for interim periods.

Recommendation

sell

The company faces severe liquidity challenges, explicitly stating a 'going concern' doubt from both management and its auditors, with current cash only projected to last into Q1 2026. While mmWave revenue growth is positive, it is insufficient to offset the overall revenue decline from the memory IC end-of-life and the high cash burn from operations. The ongoing strategic review and unsolicited acquisition proposals introduce significant uncertainty and potential for further dilution or unfavorable terms. Given the substantial financial risks, including recurring losses, negative cash flow from operations, and the urgent need for capital, a seasoned investor would likely recommend selling to mitigate exposure to a highly speculative and distressed asset.

Keywords

mmWave, semiconductor, wireless technology, 60 GHz, 5G, fabless, going concern, strategic review, Mobix Labs, acquisition, warrants, ATM offering, Nasdaq compliance, financial results, Q3 2025, Peraso Inc.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.